Potential adverse interaction of human cardiac calsequestrin
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference62 articles.
1. Contemporary management of depression;Andrews;Am. J. Med.,1994
2. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial;Ballard;Lancet Neurol.,2009
3. Early and late sarcoplasmic reticulum changes in doxorubicin cardiomyopathy. An ultrastructural investigation with the zinc iodide–osmium tetroxide (ZIO) technique;Bellini;Virchows Arch. B Cell Pathol. Incl. Mol. Pathol.,1985
4. Ryanodine and an iodinated analog: doxorubicin effects on binding and Ca2+ accumulation in cardiac sarcoplasmic reticulum;Bowling;Eur. J. Pharmacol.,1994
5. Relation between structure and function of a/b proteins;Bränden;Q. Rev. Biophys.,1980
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Doxorubicin Disrupts the Calcium Homeostasis through its Antagonistic Activity on PINK1–An In-silico Approach;Biointerface Research in Applied Chemistry;2022-02-12
2. Doxorubicin and its proarrhythmic effects: A comprehensive review of the evidence from experimental and clinical studies;Pharmacological Research;2020-01
3. First Insight on Small Molecules as Cardiac Calsequestrin Stabilizers;ACS Omega;2019-07-02
4. Dantrolene sodium increases calcium binding by human recombinant cardiac calsequestrin and calcium loading by sheep cardiac sarcoplasmic reticulum;Acta Physiologica;2019-03-04
5. The Anthracycline Metabolite Doxorubicinol Abolishes RyR2 Sensitivity to Physiological Changes in Luminal Ca2+ through an Interaction with Calsequestrin;Molecular Pharmacology;2017-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3